The New Rasputins
Anti-science mysticism is enabling autocracy around the globe.
Related Articles
Functional evaluation and clinical classification of BRCA2 variants
Nature – Results from a comprehensive evaluation of the function of BRCA2 variants, particularly variants of uncertain significance, provide a useful resource to improve the…
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
Nature Medicine – This analysis of the registry database DESCAR-T of more than 3,000 pediatric and adult patients with hematological malignancies who received CAR T cell…
Use of a clinical trial screening tool to enhance patient accrual
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Impact of Broadening Trial Eligibility Criteria for Patients with Advanced Non–Small Cell Lung Cancer: Real-World Analysis of Select ASCO-Friends Recommendations
AbstractPurpose:. Cancer clinical trials often accrue slowly or miss enrollment targets. Strict eligibility criteria are a major reason. Restrictive criteria also limit opportunities for patient…
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group
AbstractPurpose:. Performance status (PS) is one of the most common eligibility criteria. Many trials are limited to patients with high-functioning PS, resulting in important differences…
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group
AbstractPurpose:. Washout periods and concomitant medication exclusions are common in cancer clinical trial protocols. These exclusion criteria are often applied inconsistently and without evidence to…
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO–Friends of Cancer Research Joint Research Statement
AbstractPurpose:. Restrictive clinical trial eligibility criteria (EC) limit the number of patients who can enroll and potentially benefit from protocol-driven, investigational treatment plans and reduce…
Critical Recent NCCN Guideline Updates Affect Dozens of Malignancies
Experts detail how recent NCCN guideline changes in dozens of tumor types are affecting their practices, and we gather all the NCCN updates in a…
Make it your resolution to attend HOPE Summit in 2025 – LUNGevity Foundation – OncoDaily
Make it your resolution to attend HOPE Summit in 2025 – LUNGevity Foundation / cancer, HOPE Summit 2025, LUNGevity Foundation, OncoDaily, Oncology
More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma | ASH Clinical News | American Society of Hematology
Katie Robinson is a medical writer based in New York. Autologous hematopoietic cell transplantation (AHCT) is a global standard of care for eligible patients with…
